Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia

摘要

BackgroundAcute myeloid leukemia (AML) is a rapidly progressing blood cancer for which new treatments are needed. We sought to promote patient-focused drug development (PFDD) for AML by developing and piloting an instrument to prioritize the worries of patients with AML.